Tardive dyskinesia exacerbated after ingestion of phenylalanine by schizophrenic patients

Neuropsychopharmacology

Volumn 16, Issue 2, 1997, Pages 136-146

  Mosnik, Diane M ^a,b,d   Spring, Bonnie ^a,b   Rogers, Keith ^c   Baruah, Sankar ^c  

^a UNIVERSITY OF IOWA   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

amino acids; phenylalanine; schizophrenia; tardive dyskinesia

Indexed keywords

NEUROLEPTIC AGENT; PHENYLALANINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DIET; HUMAN; MALE; PRIORITY JOURNAL; PROVOCATION TEST; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

EID: 0031081237     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(96)00054-1     Document Type: Article

References (64)

1. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders (3rd ed. revised). Washington, DC
2. Antelman SM, Edwards DJ, Lin M (1977): Phenylethylamine: Evidence for a direct, postsynaptic dopamine-receptor stimulating action. Brain Res 127:317-322
3. Barnes TRE (1987): The present state of tardive dyskinesia and akathisia in the treatment of schizophrenia. Psychiatric Dev 4:301-319
4. Benson DF, Blumer D (1982): Psychiatric Aspects of Neurologic Disease, vol 2. New York, Grune & Stratton
5. Bjerkenstedt L (1990): Decreased tyrosine transport in schizophrenic patients. In Richardson MA (ed), Amino Acids in Psychiatric Disease. Washington, DC, American Psychiatric Press, pp 161-170
6. Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel FA (1985): Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br J Psychiatry 147:276-282
7. Caballero B, Wurtman RJ (1987): Control of plasma phenylalanine levels. In Wurtman RJ, Ritter-Walker E (eds), Dietary Phenylalanine and Brain Function. Boston, Birkhauser, pp 9-23
8. Carroll BJ, Curtis GC, Keekmen E (1977): Paradoxical response to dopamine agonists in tardive dyskinesia. Am J Psychiatry 1134:785-789
9. Casey DE (1987): Tardive dyskinesia. In Meltzer HY (ed), Psychopharmacology: The Third Generation of Progress. New York, Raven Press, pp 1411-1419
10. Curtius H-CH, Niederwieser A, Viscontini M, Leimbacher W, Wegman H, Blehova B, Rey F, Schaub J, Schmidt H (1981): Serotonin and dopamine synthesis in phenylketonuria. Adv Exp Med Biol 133:277-291
11. de Belleroche J, Recordati A, Clifford Rose, F (1984): Elevated levels of amino acids in the CSF of motor neuron disease patients. Neurochem Pathol 2:1-6
12. DeVeaugh-Geiss J (1982): Tardive Dyskinesia and Related Involuntary Movement Disorders. Boston, John Wright
13. During MJ, Acworth IN, Wurtman RJ (1988): Phenylalanine administration influences dopamine release in the rat's corpus striatum. Neurosci Lett 93:91-95
14. Ebadi M, Hama Y (1988): Dopamine, GABA, cholecystokinin and opioids in neuroleptic-induced tardive dyskinesia. Neurosci Biobehav Rev 12:179-187
15. Fernstrom JD, Faller DV (1978): Neutral amino acids in the brain: Changes in response to food ingestion. J Neurochemistry 30:1531-1538
16. Fernstrom JD, Wurtman RJ (1972): Brain serotonin content: Physiological regulation by plasma neutral amino acids. Science 178:414-416
17. Fibiger HC, Lloyd KG (1984): Neurobiological substrates of tardive dyskinesia: The GABA hypothesis. Trends Neurosci 7:462-464
18. Gardos G, Cole JO, Matthews JD, Nierenberg AA, Dugan SJ (1992): The acute effects of a loading dose of phenylalanine in unipolar depressed patients with and without tardive dyskinesia. Neuropsychopharmacology 6:241-247
19. Gerlach J, Reisby N, Randrup A (1974): Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia 34:21-35
20. Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel F-A (1984): Amino acids in plasma and CSF and monoamine metabolites in CSF: Interrelationship in healthy subjects. J Neurochemistry 42:833-837
21. Harper AE (1984): Phenylalanine metabolism. In Stegink LD, Filer LJ Jr (eds), Aspartame: Physiology and Biochemistry. New York, Marcel Dekker, pp 77-109
22. Hernandez T, Coulson RA (1961): The effect of insulin on amino acid metabolism. Biochemistry J 79:596
23. Ikeda M, Levitt M, Udenfriend S (1967): Phenylalanine as a substrate and inhibitor of tyrosine hydroxylase. Arch Biochem Biophys 120:420-427
24. Jeste DV, Wyatt RJ (1981): Changing epidemiology of tardive dyskinesia: An overview. Am J Psychiatry 138:297-309
25. Kane JM, Smith JM (1982): Tardive dyskinesia: Prevalence and risk factors, 1959-1979. Arch Gen Psychiatry 39:473-481
26. Kane JM, Woerner M, Lieberman JA, Weinhold P, Florio W, Rubinstein M, Rotrosen J, Kurucz J, Mukherjee S, Bergman K, Schooler NR (1985): The prevalence of tardive dyskinesia. Psychopharmocol Bull 21:136-139
27. Katz I, Lloyd T, Kaufman S (1976): Studies on phenylalanine and tyrosine hydroxylation by rat brain tyrosine hydroxylase. Biochim Biophys Acta 445:567-578
28. Koh ET, Cha CJ (1983): Comparison of plasma amino acids by race, sex, and age. Nutr Rep Int 28:8-22
29. Krause W, Halminski M, McDonald L, Dembure P, Salvo R, Freides D, Elsas L (1985): Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. J Clin Invest 75:40-48
30. Lakke JPWF, Teelken AW (1976): Amino acid abnormalities in cerebrospinal fluid of patients with Parkinsonism and extrapyramidal disorders. Neurology 26:489-493
31. Lenda K, Svenneby G (1980): Rapid high-performance liquid chromatographic determination of amino acids in synaptosomal extracts. J Chromatogr 198:516-519
32. Lindroth P, Mopper K (1979): High performance liquid chromatographic determination of subpicomole amounts of amino acids by precolumn fluorescence derivatization with ophthalidialdehyde. Anal Chem 51:1667-1674
33. Lippman RW (1958): The significance of heterozygocity for hereditary metabolic errors related to mental deficiency (oliqomentia). Am J Ment Defic 63:320-324
34. Maher TJ (1990): Effects of phenylalanine on the synthesis, release, and function of catecholaminergic systems. In Richardson MA (ed), Amino Acids in Psychiatric Disease. Washington, DC, American Psychiatric Press
35. Melamed E, Hefti F, Wurtman RJ (1980): Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions. Proc Nat Acad Sci 77:4305-4309
36. Milner JD, Irie K, Wurtman RJ (1986): Effects of phenylalanine on the release of endogenous dopamine from rat striatal slices. J Neurochemistry 47:1444-1448
37. Myslobodsky MS, Tomer R, Holden T, Kempler S, Sigal M (1985): Cognitive impairment in patients with tardive dyskinesia. J Nerv Ment Dis 173:156-160
38. Nasrallah HA, Dunner FJ, McCalley-Whitters M, Smith RE (1986): Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: Implications for clinical management. J Clin Psychiatry 47:56-59
39. National Institute of Mental Health, Psychopharmacology Research Branch (1975): Development of a dyskinetic movement scale. ECDEU Intercom 4:(1)3-6
40. Oates JA, Nirenberg PZ, Jepson JB, Sjoerdsma A, Udenfriend S (1963): Conversion of phenylalanine to phenylethylamine in patients with PKU. Proc Soc Exp Biol Med 112:1078-1081
41. Oldfield, RC (1971): The assessment and analysis of handedness: The Edinburgh Inventory. Neuropsychologia 9:97-113
42. Owens DGC, Johnstone EC, Frith CD (1982): Spontaneous involuntary disorders of movement: Their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Arch Gen Psychiatry 39:452-461
43. Pardridge WM, Choi TB (1986): Neutral amino acid transport at the human blood-brain barrier. Fed Proc 45:2073-2078
44. Pardridge WM, Oldendorf WH (1977): Transport of metabolic substrates through the blood-brain barrier. J Neurochem 28:5-12
45. Poisner AM (1960): Serum phenylalanine in schizophrenia: Biochemical genetic aspects. J Nerv Ment Dis 131:74-76
46. Potkin SG, Cannon-Spoor HE, DeLisi LE, Neckers LM, Wyatt RJ (1983): Plasma phenylalanine, tyrosine, and tryptophan in schizophrenia. Arch Gen Psychiatry 40:749-752
47. Pratt OE (1982): Transport inhibition in the pathogenesis of phenylketonuria and other inherited metabolic diseases. J Inherited Metab Dis 2(Suppl):75-81
48. Reveley MA, De Belleroche J, Recordati A, Hirsch SR (1987): Increased CSF amino acids and ventricular enlargement in schizophrenia: A preliminary study. Biol Psychiatry 22:413-420
49. Rey A (1964): L'examen clinique en psychologie. Paris, Presses Universitaires de France
50. Richardson MA, Casey DE (1988): Tardive dyskinesia status: Stability or change. Psychopharmocol Bull 24:471-475
51. Richardson MA, Haugland G, Pass R, Craig TJ (1986): The prevalence of tardive dyskinesia in a mentally retarded population. Psychopharmacol Bull 22:243-249
52. Richardson MA, Suckow R, Whittaker R, Boggiano W, Sziraki I, Kushner H, Perumal A (1989): The plasma phenylalanine/large neutral amino acid ratio: A risk factor for tardive dyskinesia. Psychopharmacol Bull 25:1-12
53. Saltz BL, Kane JM, Woerner MG, Lieberman JA, Alvir J, Blank K, Kahaner K, Foley C (1989): Prospective study of tardive dyskinesia in the elderly. Psychopharmacol Bull 25:52-56
54. Schooler N, Kane J (1982): Research diagnosis for tardive dyskinesia (RD-TD). Arch Gen Psychiatry 39:486-487
55. Simpson GM, Lee JH, Zoubok B, Gardos G (1979): A rating scale for tardive dyskinesia. Psychopharmacology 64:171-179
56. Smith JM, Baldessarini RJ (1980): Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch Gen Psychiatry 37:1368-1373
57. Serokin JE, Giordani B, Mohs RC, Losonczy MF, Davidson M, Siever LJ, Ryan TA, Davis KL (1988): Memory impairment in schizophrenic patients with tardive dyskinesia. Biol Psychiatry 23:129-135
58. Stegink LD, Filer LJ (1984): Aspartame: Physiology and Biochemistry. New York, Marcel Dekker
59. Stegink LD, Wolf-Novak LC, Filer LJ, Bell EF, Ziegler EE, Kraus WL, Brummel MC (1987): Aspartame-sweetened beverage: Effect on plasma amino acid concentrations in normal adults. Journal of Nutrition 117:1989-1995
60. Taylor EM (1959): The Appraisal of Children with Cerebral Deficits. Cambridge, MA, Ballinger
61. Wade JB, Taylor MA, Kasprisin A, Rosenberg S, Fiducia D (1987): Tardive dyskinesia and cognitive impairment. Biol Psychiatry 22:393-395
62. Wolf ME, Mosnaim AD (1988): Tardive Dyskinesia: Biological Mechanisms and Clinical Aspects. Washington, DC, American Psychiatric Press
63. Wurtman RJ (1983): Neurochemical changes following high-dose aspartame with dietary carbohydrates. N Engl J Med 309:429-430
64. Yassa R, Nair NPV, Iskandar H, Schwartz G (1990): Factors in the development of severe forms of tardive dyskinesia. Am J Psychiatry 147:1156-1163